Epidemiology of rubella virus cases in the pre-vaccination era of Ethiopia, 2009-2015

被引:11
|
作者
Getahun, Mekonen [1 ]
Beyene, Berhane [1 ]
Gallagher, Kathleen [2 ]
Ademe, Ayesheshem [2 ]
Teshome, Birke [1 ]
Tefera, Mesfin [1 ]
Asha, Anjelo [1 ]
Afework, Aklog [1 ]
Assefa, Esete [1 ]
HaileMariam, Yoseph [1 ]
HaileGiorgis, Yonas [2 ]
Ketema, Hiwot [1 ]
Shiferaw, Dejenie [1 ]
Bekele, Ayenachew [1 ]
Jima, Daddi [1 ]
Kebede, Amha [1 ]
机构
[1] Ethiopian Publ Hlth Inst, Arbegnoch St,POB 1242, Addis Ababa, Ethiopia
[2] WHO Country Off, Addis Ababa, Ethiopia
关键词
Ethiopia; Rubella; Pre-vaccine era; 2009-2015;
D O I
10.1186/s12889-016-3841-z
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Rubella is a common mild rash illness caused by rubella virus. The majority of infections occur in children and young adults. The infection is the cause of a serious birth defect known as Congenital Rubella Syndrome (CRS) when a woman acquires infection early in pregnancy. Ethiopia has not yet established rubella virus surveillance and has not yet introduced rubella vaccine into the routine immunization program. We characterize the epidemiology of laboratory confirmed rubella virus cases collected through measles surveillance from 2009 to 2015 to better understand the burden of the disease in the country. Methods: A descriptive analysis was made to characterize rubella cases reported through the national measles case based surveillance system. The measles case definition was used to capture potential rubella cases. A suspected measles case was a person with generalized rash and fever with cough, or coryza or conjunctivitis. Those cases whose sera were negative for measles IgM antibodies were tested for rubella IgM antibody. A confirmed rubella case was a person who tested positive for rubella IgM. Only laboratory confirmed rubella cases were analyzed in this article. Results: Between 2009 and 2015, a total of 28,284 serum/plasma samples were collected and tested for measles IgM antibody and 11,151 (39.4%) were found positive. A total of 17,066 measles IgM negative or indeterminate samples were tested for rubella virus IgM and 2615 (15.3%) were found positive during the same period. Of 2615 confirmed rubella cases, 52.2% were females. The age of confirmed cases ranged from one month to 42 years with a mean age of 7.3 years. Three-fourth of all confirmed rubella cases were aged less than 10 years. The number of laboratory confirmed rubella cases linearly increased from 83 in 2009 to 856 in 2013 but dropped to 222 and 319 in 2014 and 2015 respectively. Higher number of cases occurred in the hot dry season (January through June) and in the central and western part of Ethiopia with 127 lab-confirmed outbreaks in the study period. Conclusions: Based on our analysis, rubella was found to be endemic throughout Ethiopia. Children below the age of 10 years were the most affected. The burden of rubella cases varied from year to year but had a seasonal peak in March. To better understand the magnitude of rubella prior to vaccine introduction, establishing rubella surveillance system, conducting sero-prevalence studies among child bearing age females and establishing CRS sentinel surveillance among young infants are critical.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 50 条
  • [1] Epidemiology of rubella virus cases in the pre-vaccination era of Ethiopia, 2009–2015
    Mekonen Getahun
    Berhane Beyene
    Kathleen Gallagher
    Ayesheshem Ademe
    Birke Teshome
    Mesfin Tefera
    Anjelo Asha
    Aklog Afework
    Esete Assefa
    Yoseph HaileMariam
    Yonas HaileGiorgis
    Hiwot Ketema
    Dejenie Shiferaw
    Ayenachew Bekele
    Daddi Jima
    Amha Kebede
    [J]. BMC Public Health, 16
  • [2] Rubella IgM epidemiology in the pre-rubella vaccination era in Uganda
    Bagenda, Fred
    Mulogo, Edgar Mugema
    Apecu, Richard Onyuthi
    Kisakye, Anette
    Opar, Benard Toliva
    [J]. BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [3] Epidemiology of acute rubella infection in Zambia during the pre-vaccination period (2005–2016) as a baseline for monitoring rubella epidemiology in the post-rubella vaccine introduction era
    Mazyanga L. Mazaba
    Seter Siziya
    Mwaka Monze
    Daniel Cohen
    [J]. BMC Infectious Diseases, 20
  • [4] Rubella IgM epidemiology in the pre-rubella vaccination era in Uganda
    Fred Bagenda
    Edgar Mugema Mulogo
    Richard Onyuthi Apecu
    Anette Kisakye
    Benard Toliva Opar
    [J]. BMC Infectious Diseases, 20
  • [5] The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies
    Edmunds, WJ
    Gay, NJ
    Kretzschmar, M
    Pebody, RG
    Wachmann, H
    [J]. EPIDEMIOLOGY AND INFECTION, 2000, 125 (03): : 635 - 650
  • [6] Epidemiology of acute rubella infection in Zambia during the pre-vaccination period (2005-2016) as a baseline for monitoring rubella epidemiology in the post-rubella vaccine introduction era
    Mazaba, Mazyanga L.
    Siziya, Seter
    Monze, Mwaka
    Cohen, Daniel
    [J]. BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [7] NATURAL IMMUNITY TO MEASLES, RUBELLA AND MUMPS AMONG SPANISH CHILDREN IN THE PRE-VACCINATION ERA
    ARROYO, M
    ALIA, JM
    MATEOS, ML
    CARRASCO, JL
    BALLESTEROS, F
    LARDINOIS, R
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1986, 15 (01) : 95 - 100
  • [8] Epidemiology of Herpes Zoster in the pre-vaccination era: establishing the baseline for vaccination programme's impact in Spain
    Risco Risco, Carlos
    Herrador, Zaida
    Lopez-Parea, Noemi
    Martinez-Urbistondo, Diego
    del Villar Carrero, Rafael Suarez
    Masa-Calles, Josefa
    [J]. EUROSURVEILLANCE, 2023, 28 (08) : 25 - 34
  • [9] ADULT VACCINATION MARKET UPTAKE, 2009-2015
    Mao, J.
    Buikema, A. R.
    Tong, J.
    Korrer, S. D.
    Van Voorhis, D. L.
    Song, R.
    Elliott, C.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A86 - A86
  • [10] Epidemiology and genetic diversity of group A rotavirus in acute diarrhea patients in pre-vaccination era in southwest China
    Zhang, Shunxian
    Yin, Jianwen
    Yang, Jinhui
    Tian, Liguang
    Li, Dandi
    Zhang, Qing
    Chen, Jiaxu
    Xu, Wen
    Zhou, Xiaonong
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (01) : 71 - 78